Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Exelon Patch

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Supplier Contact Email Supplier's Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    Interquim SA mheras@ferrer.com https://www.pharmacompass.com/pharma-services/api-manufacturing-services/interquim-sa
    Spain
    		 Interquim S. A. 301MF10032 Rivastigmine 2019-07-19 2019-07-19 Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain
    Aurobindo Pharma Limited enquiries@pharmacompass.com https://www.pharmacompass.com/api-manufacturers/aurobindo-pharma-limited
    India
    		 Aurobindo Pharma Limited 301MF10019 Rivastigmine 2019-06-18 2020-05-12 Plot No. 2, Maitrivihar, Ameerpet, Hyderabad Telangana, India
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.